Русский / English
Enter the query
News
Press Center
phone: +7 495 785 29 07
fax: +7 499 230 32 94
press@interros.ru
Contacts
Calendar
prev next June 2023
Mon Tue Wed Thu Fri Sat Sun
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30
17.09.2018
Sustainable Tourism: Global Challenges and Discovering Russia, an international conference, will take place in Sochi from the 17th to the 20 th of October. Well-known subject-matter experts, managers of natural protected areas, specialized tour operators, experienced guides, industry representatives and environmentalists from all over the world will gather for a comprehensive discussion about challenges, opportunities and milestones on the path towards sustainable development of ecotourism in Russia and worldwide; they will also outline a plan to cooperate in order to achieve further progress.
More Topics Rosa Khutor
11.09.2018
1.5 to 1.7 million tonnes of sulphur dioxide per year is projected to be captured from now to 2023. Its by-product: elemental sulphur and gypsum, of which Nornickel will acquire 280,000 and 5 million tonnes per year respectively.
More
06.09.2018
In 2018, Petrovax Pharm’s pharmaceutical complex in Moscow Region marked its 10th anniversary. The company has commemorated the event by manufacturing the first batches of Grippol®Quadrivalent and making a presentation of the third production line for API as well as suppository and tablet dosage forms.
More
06.08.2018
In July 2018, Petrovax Pharm received Marketing Authorization No. LP-004951 for Grippol® Quadrivalent, a 4-valent inactivated subunit adjuvanted vaccine designed for prevention of influenza. It is the most advanced flu vaccine in the world that employs an antigen sparing technology and has a high preventive activity and safety.
More Topics Petrovax Pharm
16.07.2018
The event took place within the framework of the educational project «We and Media». Participants of the round table discussed ways of fighting dangerous infectious diseases and the role of the media in the popularization of the vaccine prophylaxis.
More Topics Petrovax Pharm